A retrospective pilot study to determine whether the reproductive tract microbiota differs between women with a history of infertility and fertile women by Wee, BA et al.
"This is the peer reviewed version of the following article: [Wee, B. A., Thomas, M., 
Sweeney, E. L., Frentiu, F. D., Samios, M., Ravel, J., Gajer, P., Myers, G., Timms, P., 
Allan, J. A. and Huston, W. M. (2017), A retrospective pilot study to determine whether 
the reproductive tract microbiota differs between women with a history of infertility and 
fertile women. Aust N Z J Obstet Gynaecol. doi:10.1111/ajo.12754.], which has been 
published in final form at [doi: 10.1111/ajo.12754] This article may be used for non-
commercial purposes in accordance with Wiley Terms and Conditions for Self-Archiving." 
 
A retrospective pilot study to examine if the reproductive tract microbiota differs in 
women with a history of infertility compared to fertile women. 
Bryan A Wee#: Bryan.Wee@qut.edu.au, Institute of Health and Biomedical Innovation, 
Queensland University of Technology, Kelvin Grove QLD 4059, Australia. 
Mark Thomas#: Mark.Thomas@student.uts.edu.au, School of Life Sciences, Faculty of 
Science, University of Technology Sydney, Broadway NSW, 2007, Australia. 
Emma Louise Sweeney: el.sweeney@qut.edu.au, Institute of Health and Biomedical 
Innovation, Queensland University of Technology, Kelvin Grove QLD 4059, Australia. 
Francesca D Frentiu: Francesca.Frentiu@qut.edu.au, Institute of Health and Biomedical 
Innovation and School of Biomedical Sciences, Queensland University of Technology, Kelvin 
Grove QLD 4059, Australia. 
Melanie Samios: melaniesamios@yahoo.com, School of Medicine, Griffith University and UC 
Health Clinical School, The Wesley Hospital, Auchenflower QLD 4066, Australia. 
Jacques Ravel: jravel@som.umaryland.edu, Institute for Genome Sciences, University of 
Maryland School of Medicine, Baltimore, MD 20201, USA. 
Pawel Gajer: pgajer@gmail.com, Institute for Genome Sciences, University of Maryland 
School of Medicine, Baltimore, MD 20201, USA. 
Garry Myers; garry.myers@uts.edu.au, ithree institute, University of Technology Sydney, 
Ultimo, NSW 2007, Australia. 
Peter Timms: ptimms@usc.edu.au, Faculty of Science, Health, Education and Engineering, 
University of the Sunshine Coast, Maroochydore, QLD 4558, Australia. 
John A Allan: John.Allan@uchealth.com.au, UC Health Clinical School, The Wesley Hospital, 
Auchenflower, QLD 4066, Australia; and Wesley Medical Research, The Wesley Hospital, 
Auchenflower, QLD 4066,Australia. 
Wilhelmina M Huston: Wilhelmina.Huston@uts.edu.au, Wesley Medical Research, The 
Wesley Hospital, Auchenflower, QLD 4066, Australia, and Wesley Medical Research, The 
Wesley Hospital, Auchenflower, QLD 4066, Australia, and Institute of Heath and Biomedical 
Innovation, Queensland University of Technology, Kelvin Grove, QLD 4095 Australia; and 
School of Life Sciences, University of Technology Sydney, Ultimo, NSW 2007, Australia. 
#these authors contributed equally to the study 
 
* corresponding author, email Wilhelmina.Huston@uts.edu.au,  Phone +61 2 95143449, Post 
to: School of Life Sciences, Building 4 City Campus, University of Technology Sydney, PO 
BOX 123, Broadway, NSW 2007, Australia. 
Acknowledgements 
The researchers would like to acknowledge The Wesley Medical Research Institute Tissue 
Bank for help with facilitating specimen collection. We especially acknowledge Emma 
Raymond and Rebecca Rogers from the Tissue bank. The authors acknowledge the clinical 
team and staff at The Wesley Hospital who helped specimen collections on the day of surgery.  
 
Competing interests  
The authors declare that they have no competing interests. 
Funding 
This research was funded by The Wesley Medical Research Institute project grant awarded to 
JAA and WMH. The authors gratefully acknowledge the Institute for the funding. The Wesley 
Medical Research funding agency did not have any role in the interpretation or analysis of the 
data or manuscript drafting. Dr Huston and Associate Professor Allan held honorary 
appointments at the Institute. 
Author contributions 
BAW conducted all bioinformatics analysis and contributed to the drafting of the manuscript. 
MT conducted laboratory components, RT-qPCR and related statistical analysis and 
contributed to the drafting of the manuscript. ELS contributed to the design and interpretation 
of RT-qPCR and contributed to the drafting of the manuscript. FDF contributed to the design 
and interpretation of RT-qPCR and contributed to the drafting of the manuscript. MS 
contributed to participant recruitment, questionnaire design and data collection, and 
contributed to the drafting of the manuscript. JR contributed to bioinformatics design and 
analysis of the microbiota data and contributed to the drafting of the manuscript. PG 
contributed R scripts, bioinformatics design and analysis of the microbiota data and contributed 
to the drafting of the manuscript. GM contributed to bioinformatics design and analysis of the 
microbiota data and contributed to the drafting of the manuscript. PT contributed to design and 
interpretation of RT-qPCR and contributed to the drafting of the manuscript. JAA conceived 
the concept of the study, conducted clinical recruitment, epidemiological and questionnaire 
analysis and contributed to the drafting of the manuscript. WMH developed the case-control 
study design, contributed to statistical analysis and interpretation and contributed to the 
drafting of the manuscript. 
  
 Abstract 
Background: We know very little about the microbiota inhabiting the upper female 
reproductive tract and how it impacts on fertility.  
Aims: This pilot study aimed to examine the vaginal, cervical, and endometrial microbiota 
for women with a history of infertility compared to women with a history of fertility.  
Materials and Methods: Using a retrospective case-control study design, women were 
recruited for collection of vaginal, cervical and endometrial samples. The microbiota 
composition was analysed by 16S rRNA gene amplification and endometrial expression of 
selected human genes by qRT-PCR. 
Results:  Sixty-five specimens from the reproductive tract of 31 women were successfully 
analysed using 16S rRNA gene amplicon sequencing (16 controls and 15 cases). The 
dominant microbial community members were consistent in the vagina and cervix, and 
generally consistent with the endometrium although the relative proportions varied. We 
detected three major microbiota clusters that did not group by tissue location or case-control 
status. There was a trend that infertile women more often had Ureaplasma in the vagina and 
Gardnerella in the cervix. Testing for the expression of selected genes in the endometrium 
did not show evidence of correlation with case-control status, or with microbial community 
composition, although Tenascin-C expression correlated with a history of miscarriage.  
Conclusions: There is a need for further exploration of the endometrial microbiota, and how 
the microbiota members or profile interplays with fertility or assisted reproductive 
technologies.  
 
Background 
The vaginal microbiota has an established role in female reproductive tract physiology, 
pathogen defense, and function [1, 2]. In 2011, the vaginal microbiota of reproductive-age 
women was characterized by 16S rRNA gene amplicon sequencing, leading to the 
identification of five community state types (CST) [3]. These were defined by the presence or 
absence of a dominant Lactobacillus spp., including CST I: Lactobacillus (L.) crispatus, II: L. 
gasseri, III: L iners, IV: a diverse array of strict and facultative anaerobes lacking a dominant 
Lactobacillus spp., and V: L. jensenii [3]. Longitudinal analysis subsequently showed that the 
vaginal microbiota is highly dynamic, with changes observed after sexual contact, menses, 
douching, and lubricant use [4]. Although, a separate study using CPN60 profiling reported 
community stability throughout the menstrual cycle [5].  
There are few studies of the upper reproductive tract microbiota. Analysis of vaginal, 
cervical, and endometrial specimens after insertion of an intrauterine levonorgestrel device 
(LNG IUS) found a microbiota shift towards Lactobacillus crispatus [6]. Species-specific PCR 
analysis of hysterectomy samples demonstratedthat the upper reproductive tract microbiota did 
not correlate with selected host inflammatory markers [7]. Upon examining the tip of the 
transfer catheter used for embryo transfer during IVF [8], a lower relative abundance of 
Pseudomonas spp. and Flavobacterium spp. was present in women who proceeded to 
successful pregnancy [8]. The diversity of the vaginal microbiota in women undergoing in vitro 
fertilization embryo transfer was higher for women who had a live birth from the cycle [9]. 
The presence of a non-Lactobacillus dominant microbiota in the endometrium correlated with 
IVF embryo transfer failure [10]. While these reports support that the reproductive tract 
microbiota impacts fertility and pregnancy outcomes, much remains to be tested, such as 
examining infertility or pregnancy outcomes in the context of specific taxa, species level 
analysis, or the community state types/profiles. In this pilot study, we sought to examine the 
possible association of the reproductive tract microbiota with women who have a current or 
recent past history of infertility.  
Method 
Study design 
We designed a pilot case-control study of the reproductive tract microbiota of women with a 
recent previous or current history of infertility (Cases), compared to women with no history of 
infertility (Controls) (Table 1). Women already undergoing hysteroscopy for a variety of 
reasons, excluding suspected cancer, were invited to participate.  Participants categorized as 
Cases were currently attending gynecological or fertility care, or attending for other 
gynecological reasons but had a recent previous history of infertility that required assisted 
reproductive technologies. Inclusion criteria for Cases were women who had reported greater 
than a year of trying to achieve pregnancy, and who currently or previously required assisted 
reproductive technologies to achieve pregnancy. Five women in the infertile group were 
undergoing treatment for infertility at the time of recruitment; the remaining ten were having 
treatment for other gynecological reasons, having previously required assisted reproductive 
technologies to achieve pregnancy. Given the retrospective and pilot nature of this study, type 
of infertility was not an inclusion or exclusion criteria. Participants recruited to the Control 
group were women who had a history of pregnancies with no need for assisted reproductive 
technologies, and who were attending gynecological care for a hysteroscopy procedure for 
gynecological care (hysteroscopy for an IUD (IUS) change, or hysterectomy, excluding 
suspected reproductive cancers). Gynecological and obstetric histories were collected using a 
self-completed questionnaire. Several participants who were recruited and consented to the 
study, but were 50 years or over, were used for extraction method validation and were not 
included in the analysis. Participants whose vaginal and/or other specimens did not pass 
extraction quality assessment were not included for sequencing. 
At the time of hysteroscopy in the operating theatre, a sterile speculum was inserted into the 
vagina, and swabs collected from the posterior fornix and the endocervical canal. The vagina 
was then prepared for surgery with betadine antiseptic surgical solution. An endometrial biopsy 
was collected using an endometrial curette and stored in 0.5 ml of RNALater. Study samples 
were immediately taken to the on-site Tissue Bank and frozen at -80°C, with the exception of 
the endometrial sample that was incubated overnight at 4°C to allow the preservative buffer to 
penetrate the tissue, and then frozen at -80°C the following day.   
In addition to comparing participant microbiota profiles based on case and control 
categories, we also analyzed other aspects of their gynecological history. These included the 
type of contraceptive used, any history of miscarriages, any history of endometriosis, and age 
. For contraceptives, we grouped the participants into the categories of i) pill (oral 
contraceptives), ii) LNG IUS (intrauterine levonorgestrel device) or iii) other, based on self-
reporting. The other contraceptive category included methods such as rhythm, condoms, tubal 
ligation or no use of active contraception at all. These were classified together (Other) because 
we assumed similar implications for endometrial gene expression as compared to hormonal 
contraceptives. We used the following age groups for categorical analysis: 28-33, 34-39, 40-
45, and 46-49 years old.   
Ethics approval and consent to participate 
Ethical approval to conduct this study was granted by the Uniting Care Health Human Research 
Ethics committee (Approval number 1227), Queensland University of Technology Human 
Research Ethics Committee (Approval number 1300000004), and University of Technology 
Sydney Human Research Ethics Committee (Approval number 2015000700). Participants 
provided informed written consent prior to participation in the study. 
Availability of data and material 
The dataset is available in SRA database under accession number: PRJEB18626. 
Microbiota processing, amplification and analysis 
The protocols for sample processing, 16S rRNA gene amplification, sequencing, statistical 
analysis of microbiota data, PCR for Ureaplasma, and qPCR for endometrial gene expression 
are provided as Supplementary Material 1.  
Statistical analysis 
To identify differences between cases and controls, we performed a non-parametric t-test using 
species level classifications [11], fully described in the Supplementary material 1. Plots were 
generated using the R Package Phyloseq v1.12.2 [12]. We compared the proportions or 
distributions of the demographic (age), obstetric, and gynecological factors between the case 
and control groups using SPSS (specific test indicated with the results). 
 
Results 
Case-control groups were comparable for gynecological factors, although age was 
significantly different   
This was a retrospective pilot case-control examination of the reproductive tract microbiota for 
women with a current or past history of infertility needing assisted reproductive technologies 
to conceive (Cases), compared to women with no history of infertility (Controls) (Table 1). 
The groups had similar proportions of the types of contraceptives in use, endometriosis, and 
miscarriage (Table 1). However, the number of live births, seeking pregnancy, and age were 
significantly different between the Cases and Controls.  
The endometrial microbiota appeared to have different relative abundances of 
microbiota to that in the vagina and cervix in some participants   
16S rRNA gene amplicon sequencing was performed on DNA isolated from the vagina, cervix, 
and endometrium, for samples where this could be successfully extracted (summarized in Table 
2 and Supplementary Table S2). The sequence depth per sample was variable, with the highest 
number of filtered sequences obtained from vaginal (mean=88,302) and cervical 
(mean=95,401) samples (Supplementary Table S2). Endometrial samples produced fewer 
reads ( average of 7,815 per sample).  
 
The genus Lactobacillus was most frequently observed (Figure 1). The most abundant 
taxonomic units were the same in both cervical and vaginal specimens for all 24 of the 33 
women where both were sequenced (Figure 1). In women with sequences from both the 
endometrium and vagina, half had some differences in the proportions of the most abundant 
taxa relative to the vagina. A principal coordinates analysis of the Jensen-Shannon Divergence 
showed no grouping of specimens by reproductive site, age, case-control status 
(Supplementary data Figure S1). Similarly, Alpha Diversity analysis showed a variety of 
richness across the sites and case-control status with no clear associations (Supplementary data 
Figure S1). 
 
Community clusters were analyzed using a cluster dendrogram [3] that is based on dominant 
or absent Lactobacillus species (Figure 2). Microbiota profiles were distributed across these 
community state types, with three dominant clusters apparent. Community state type I (CSTI; 
L. crispatus dominant), CSTIII (L. iners dominant), and CSTIV were most common. Generally, 
each individual’s specimens (vaginal, cervical, and endometrial) clustered together with the 
exception of three endometrial samples and one vaginal sample that featured a mix of 
Corynebacterium, and Propionibacterium, that formed a cluster. 
 
There were possible sub-clusters within the CSTIV (with CST II or dominant L. gasseri within 
this group). These were dominated by Gardnerella vaginalis (with Prevotella in some cases) 
(consistent with CSTIV [3], CST IV-B [4]),  or Streptococcus agalactiae /Streptocococcus 
anginosus were dominant (consistent with CST IV-A [4]); or  Bifidobacterium  (also as 
described in another study [5]). However, while consistent with previously reported sub-
clusters, these clusters would need a larger sample size to resolve.  
 
Women with a past history of infertility showed a trend towards having Ureaplasma spp. 
in the vagina and Gardnerella in the cervix 
We observed a trend for two organisms to be more abundant or prevalent in the Cases 
(Ureaplasma spp., p=0.042 (vagina) and G. vaginalis, p=0.044 (cervix); unadjusted). A 
Ureaplasma-specific PCR was used to further confirm that all five positive samples contained 
Ureaplasma parvum (Supplementary Figure S2 and S3). Four of the five women with a history 
of infertility (Cases) colonised with Ureaplasma also had a vaginal CST III dominated by L. 
iners (p= 0.015; unadjusted for multiple testing).  
 
Endometrial gene expression significantly correlated with a history of miscarriage and 
contraceptive use, but not with a history of infertility or microbiota composition 
We next assessed endometrial expression of selected genes with known endometrial function 
(IL-1, IL-6, IL-8, TN-C, TNF, and SDC1). There were no significant differences in the 
expression of these genes in relation to case-control status (Figure 3A, B). High expression of 
TN-C grouped in two clusters on a linkage dendrogram and was higher in women with a history 
of miscarriage (p<0.001, Figure 3C). IL-6 expression levels were higher in LNG IUS users 
(p=0.05), whereas SDC1 was significantly lower in LNG IUS users compared to OCP users 
(p<0.01, Figure 3D).  
Discussion 
The objective of this pilot study was to examine the reproductive tract microbiota (vagina, 
cervix, and endometrium) in women with a history of needing fertility treatment for pregnancy 
compared to fertile controls. We observed some differences in the upper reproductive tract 
(endometrium) compared to the vagina and cervix within individual participants. Furthermore, 
we showed a trend of Gardnerella in the cervix and Ureaplasma in the vagina being associated 
with women with a history of infertility, adding further support to the case that the microbiota 
should be further evaluated for relevance to fertility and assisted reproductive treatment.  
Our study has a number of limitations that should be considered when interpreting these 
results. The time of fertility status is in the past, meaning the samples were not collected when 
the women were experiencing infertility/fertility. Also,the Control group were significantly 
older. Although three reproductive sites were sampled from each participant, inconsistencies 
in DNA extraction quality and/or sequence results limited the number of individuals with 
sequenced microbiota from all three sites. This may reflect the expected relatively lower 
numbers of bacteria in the endometrium, or could indicate difficulties in DNA extraction from 
this site. The sampling protocol specified the need to avoid the surface of the vaginal canal 
when removing the cervical/endometrial sample, however we do note the potential for cross 
contamination by this technique. Additionally, it is known that the vaginal microbiome (and 
presumably also the endometrial microbiome) is affected by ethnicity, age, pregnancy, sexual 
activity, smoking and exogenous hormones [13-17]. While we were not able to control for 
several of these factors in this pilot study, we recommend that any future large-scale studies 
should attempt to do so.  
In spite of these limitations, our findings are consistent with other published studies. 
Many individuals within this study had a dominant Lactobacillus species [3, 4]. The possible 
CSTIV sub-clusters may be significant for future research. A potential Bifidobacterium 
dominant sub-cluster was present in some endometrial samples, consistent with previous work 
[10]. Ureaplasma spp. (confirmed to be U. parvum) trended towards an association with 
infertility cases in the vagina and Gardnerella in the cervix. Ureaplasma spp. have been 
identified within the reproductive tracts of both fertile and infertile women [18, 19], and have 
been associated with preterm delivery (< 37 weeks of gestation) [20, 21] and other adverse 
pregnancy outcomes [21]. Here we provide a further association of Ureaplasma with infertility. 
The different abundance and presence/absence of taxa between the upper and lower genital 
tract specimens warrants further investigation, and our pilot study provides further baseline 
data to support the need for continued investigation into the endometrial microbiota. We 
speculate that the microbiome of the endometrium could be an important factor in unexplained 
infertility and/or repeat IVF cycle failures. 
There were no differences in endometrial gene expression of our selection of target 
genes based on case-control (fertility) status. TN-C had significantly high expression in 
participants with history of miscarriage, consistent with prior reports of an association with 
recurrent miscarriage [22-25]. We also detected the expected differences in IL-6 endometrial 
gene expression in women using LNG IUS compared to other contraceptives, as this has been 
previously reported [26, 27]. SDC1 has been reported as a marker of endometritis [28, 29], and 
here we found that SDC1 was significantly downregulated in LNG IUS users.  
Our pilot study supports that the endometrium microbiota is likely to have subtle yet 
important differences from the lower reproductive tract, and even the lower reproductive tract 
microbiota may have an impact on infertility. Future studies should include much larger sample 
sizes and prospective recruitment during fertility treatment. This will permit the monitoring of 
the microbiota and endometrial tissue responses during assisted reproductive treatment cycles. 
There is already a common practice of endometrial scratching (reviewed, [30]) during the 
menstrual cycle prior to embryo transfer. We propose scratching material could be harvested 
and tested for the endometrial microbiota and expression of select endometrial genes to 
optimize embryo transfer timing. Such an innovation will require larger, longitudinal studies 
of the reproductive tract microbiota on women undergoing fertility treatment during their 
cycles.  
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Figures 
Figure 1. The relative proportion of the 25 most abundant taxonomic assignments. The 
key is to the right. The results are grouped according to the participants’ Case-Control status 
(indicated at the top). The participant codes are below the graphs with each of the three 
specimen sites shown by row(indicated to the right: Vagina, Cervix, Endometrium). Only 
samples with more than 1,000 assembled and assigned sequences are displayed.  
Figure 2. Community state types dominated by Lactobacillus were present in the majority 
of specimens. Heat map showing the proportions of the top 20 most abundant taxonomic 
groups in the reproductive tract microbiota. Contraceptive, age, history of endometriosis, 
history of miscarriage, and case/control status are displayed above each sample (color keys are 
indicated to the right). Linkage clustering of the samples to the previously defined community 
state types (CST I, II, III and IV) [3] is shown at the top of the figure.  
Figure 3. Endometrial expression of six selected genes with known implications for 
endometrial pathology or function. (A) The dendrogram shows hierarchical linkage 
clustering of IL-1, IL-6, IL-8, SDC1, TN-C and TNF- gene expression. The relevant 
participant data are shown on the right; including case-control status, presence of Ureaplasma 
spp., age, miscarriage, and contraceptive (color keys indicated to the right). Colors represent 
the transformed mean Ct values for each specimen, calculated as 2-Ct. (B) miscarriage 
history, (C) contraceptives, (D) case-control status. Graphical representation of the expression 
levels of six genes of interest relative to the geometric mean of GAPDH and PPIA levels, 
grouped according to participant data. The data displayed on the Y-axis of each graph 
represents the transformed mean Ct values of each group, calculated as 2-Ct and multiplied 
by an arbitrary factor of 100. Error bars denote the standard error of the mean, while the X-
axis displays gene names. Bar color indicates participant grouping based on (A) Statistical 
testing of data was performed using either the Kruskall-Wallis or Mann-Whitney tests (* 
p<0.05; *** p=0.0006).  
 
Supplementary Data 
Supplementary Data are available for the manuscript. 
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Table 1 
 Categories/ 
groups 
CONTROL (n=16)* 
(fertile) 
CASE (n=15) 
(infertile) 
 
Age Range (mean) 35-48 (42.75) 28-45 (37.6) p= 0.05!  
28-33 0 3 p=0.035$  
 34-39 4 7 
 40-45 8 5 
 45-49 4 0 
Ever Pregnant   16 (100%) 12 (80%) p=0.203$ 
Ever had a Live 
Birth  
 16 (100%) 11 (73.3%) p=0.086$ 
# live births median 
(interquartile 
range) 
 2.5 (2-3) 2.0 (0-2) p=0.049^ 
No longer seeking 
pregnancy 
 16 (100%) 10 (66%) p= 0.018$ 
Contraceptive # (%) Other 6 (37.5%) 9 (60%) p=0.149$ 
 Pill 4 (25%) 5 (33.3%) 
 Mirena 6 (37.5%) 
 
1 (6.6%) 
History of 
endometriosis 
Y 6 (37.5%) 6 (40.0%) p=0.589$  
N 10 (62.5%) 9 (60.0%) 
History of 
miscarriage 
Y 8 (50.0%) 5 (33.3%) p=0.283$ 
N 8 (50.0%) 10 (66.7%)  
! t test; $ Fishers exact chi-square; ^Wilcoxon rank sum test 
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